Disse resultater svarede til de immunresponsrater, som blev induceret ved samtidig administration af en enkelt dosis levende skoldkoppevaccine (Oka/ Merck) og MFR- vaccinen fremstillet af Merck & Co., Inc. på forskellige injektionssteder.
These results were similar to the immune response rates induced by concomitant administration of a single dose of Varicella Vaccine live (Oka/ Merck) and the measles, mumps, and rubella vaccine manufactured by Merck & Co., Inc. at separate injection sites.